Cubist Systematic Strategies’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-174,960
| Closed | -$7.08M | – | 1492 |
|
|
2025
Q1 | $7.08M | Buy |
174,960
+144,752
| +479% | +$5.86M | 0.04% | 340 |
|
|
2024
Q4 | $840K | Buy |
+30,208
| New | +$840K | 0.01% | 856 |
|
|
2024
Q2 | – | Sell |
-7,119
| Closed | -$180K | – | 1419 |
|
|
2024
Q1 | $180K | Buy |
7,119
+1,883
| +36% | +$47.6K | ﹤0.01% | 1699 |
|
|
2023
Q4 | $122K | Sell |
5,236
-19,010
| -78% | -$444K | ﹤0.01% | 1749 |
|
|
2023
Q3 | $1.23M | Buy |
+24,246
| New | +$1.23M | 0.01% | 966 |
|
|
2023
Q2 | – | Sell |
-19,778
| Closed | -$757K | – | 2235 |
|
|
2023
Q1 | $757K | Sell |
19,778
-95,706
| -83% | -$3.66M | ﹤0.01% | 1623 |
|
|
2022
Q4 | $6.33M | Sell |
115,484
-1,691
| -1% | -$92.7K | 0.04% | 536 |
|
|
2022
Q3 | $3.99M | Buy |
117,175
+96,932
| +479% | +$3.3M | 0.02% | 1014 |
|
|
2022
Q2 | $191K | Buy |
20,243
+12,277
| +154% | +$116K | ﹤0.01% | 3194 |
|
|
2022
Q1 | $113K | Buy |
7,966
+6,219
| +356% | +$88.2K | ﹤0.01% | 3184 |
|
|
2021
Q4 | $37K | Sell |
1,747
-1,211
| -41% | -$25.6K | ﹤0.01% | 3339 |
|
|
2021
Q3 | $66K | Sell |
2,958
-6,655
| -69% | -$148K | ﹤0.01% | 2804 |
|
|
2021
Q2 | $238K | Buy |
+9,613
| New | +$238K | ﹤0.01% | 2455 |
|
|
2021
Q1 | – | Sell |
-6,829
| Closed | -$176K | – | 2812 |
|
|
2020
Q4 | $176K | Buy |
6,829
+4,829
| +241% | +$124K | ﹤0.01% | 2284 |
|
|
2020
Q3 | $62K | Buy |
2,000
+1,280
| +178% | +$39.7K | ﹤0.01% | 2348 |
|
|
2020
Q2 | $18K | Sell |
720
-987
| -58% | -$24.7K | ﹤0.01% | 2319 |
|
|
2020
Q1 | $36K | Buy |
1,707
+658
| +63% | +$13.9K | ﹤0.01% | 2033 |
|
|
2019
Q4 | $23K | Sell |
1,049
-1,554
| -60% | -$34.1K | ﹤0.01% | 2335 |
|
|
2019
Q3 | $59K | Sell |
2,603
-1,957
| -43% | -$44.4K | ﹤0.01% | 2016 |
|
|
2019
Q2 | $87K | Buy |
+4,560
| New | +$87K | ﹤0.01% | 2254 |
|